About cresco labs - CRLBF
Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. It focuses on regulatory compliance while working to develop condition-specific strains of cannabis and non-invasive delivery methods. The company was founded by Charles Bachtel, Joseph Caltabiano, Dominic Sergi, Rob Sampson, and Brian McCormack on July 6, 1990 and is headquartered in Chicago, IL.
CRLBF At a Glance
Cresco Labs, Inc.
400 West Erie Street
Chicago, Illinois 60654
| Phone | 1-312-929-0993 | Revenue | 770.89M | |
| Industry | Agricultural Commodities/Milling | Net Income | -175,522,000.00 | |
| Sector | Process Industries | Employees | 2,760 | |
| Fiscal Year-end | 12 / 2024 | |||
| View SEC Filings |
CRLBF Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 0.57 |
| Price to Book Ratio | 0.913 |
| Price to Cash Flow Ratio | 7.506 |
| Enterprise Value to EBITDA | 7.066 |
| Enterprise Value to Sales | 1.214 |
| Total Debt to Enterprise Value | 0.729 |
CRLBF Efficiency
| Revenue/Employee | 279,306.159 |
| Income Per Employee | -63,594.928 |
| Receivables Turnover | 14.686 |
| Total Asset Turnover | 0.524 |
CRLBF Liquidity
| Current Ratio | 1.389 |
| Quick Ratio | 0.85 |
| Cash Ratio | 0.542 |
CRLBF Profitability
| Gross Margin | 43.823 |
| Operating Margin | 8.198 |
| Pretax Margin | -19.056 |
| Net Margin | -22.769 |
| Return on Assets | -11.932 |
| Return on Equity | -30.991 |
| Return on Total Capital | -14.769 |
| Return on Invested Capital | -14.509 |
CRLBF Capital Structure
| Total Debt to Total Equity | 135.014 |
| Total Debt to Total Capital | 57.449 |
| Total Debt to Total Assets | 50.259 |
| Long-Term Debt to Equity | 130.816 |
| Long-Term Debt to Total Capital | 55.663 |